Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Kidney Failure, Chronic 1

Interventions

Fluorodeoxyglucose F18 3pembrolizumab 2sacituzumab govitecan 1ibrutinib 1erdafitinib 1enzalutamide 1enfortumab vedotin 1dynorphin-converting endopeptidase 1avelumab 1apixaban 1Vinblastine 1Surveys and Questionnaires 1Specimen Handling 1Radiosurgery 1Pancreatectomy 1Paclitaxel 1Nivolumab 1Methotrexate 1Magnetic Resonance Imaging 1JNJ-64619178 1JNJ-64264681 1Inosine Monophosphate 1Health Information Exchange 1Genetic Testing 1Genetic Counseling 1Gemcitabine 1Focus Groups 1Enoxaparin 1Docetaxel 1Cystoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Pancreatectomy × Genitourinary × Clear all
NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

National Taiwan University Hospital

Enrolling by invitation
100 enrolled
GastrointestinalGenitourinary

Kidney Failure, Chronic, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡